Profile
VALN VRTX ALNY REGN ARGX SGEN
Company Name Valneva SE Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $705.45M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.71K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Thomas Lingelbach Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
VALN VRTX ALNY REGN ARGX SGEN
Quant Rating Score 1 4 1 4 4 3
Quant Rating Strong Sell Buy Strong Sell Buy Buy Neutral
Trading
VALN VRTX ALNY REGN ARGX SGEN
Last Close $8.94 $394.53 $465.89 $560 $756.38 $228.74
High 52 $12.14 $516.74 $482.13 $1153.35 $768 $228.74
Low 52 $3.69 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -26.36 % -23.65 % -3.37 % -51.45 % -1.51 % 0 %
Price vs. 52 Week Low 142.28 % 7.64 % 107.45 % 15.96 % 45.52 % 0 %
Total Return
VALN VRTX ALNY REGN ARGX SGEN
1 Month Return -14.94 % 1.08 % 5.23 % -1.06 % 15.74 % 0 %
3 Month Return 49.09 % -13.38 % 51.27 % 5.81 % 30.89 % 0 %
6 Month Return 31.64 % -21.84 % 92.71 % -16.03 % 25.03 % 0 %
9 Month Return 127.48 % -14.92 % 89.82 % -23.42 % 24.57 % 0 %
YTD Return 104.48 % -2.03 % 97.99 % -21.38 % 22.99 % 0 %
1 Year Return 40.02 % -18.72 % 75.63 % -51.45 % 40.59 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VALN VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -0.53 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
VALN VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 49.03 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -14.18 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -35.27 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -14.46 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 103.35 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 129.32 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -25.55 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -6.04 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 8.14 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 17.61 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM 1.62 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 133.15 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 41.54 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.07 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.21 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 99.33 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -6.06 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 288.98 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -6.04 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -19 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -51.91 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -51.91 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
VALN VRTX ALNY REGN ARGX SGEN
Revenue $0.17B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0.07B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 41.89% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $0.03B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.17 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
VALN VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.19B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.32B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.18B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.22B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.5B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
VALN VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $-0.01B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0.02B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.46
AARD Aardvark Therapeutics, Inc. Common Stock 8.59
ABCL AbCellera Biologics Inc. 4.47
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 6.43
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.32
ABPWW 0.0462
ABSI Absci Corporation 2.55
ABUS Arbutus Biopharma Corporation 4.46
ABVC ABVC BioPharma, Inc. 2.85
ABVX Abivax SA American Depositary Shares 84.01
ACAD ACADIA Pharmaceuticals Inc. 23.61
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8102
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.08
ACIU AC Immune SA 2.43
ETFs With Exposure to VALN
Ticker ETF Name Weight Percentage Price
IEFA iShares Core MSCI EAFE ETF 0.01 86.96
IXUS iShares Core MSCI Total International Stock ETF 0.01 81.81
SCZ iShares MSCI EAFE Small-Cap ETF 0.04 76.81
IEUS iShares MSCI Europe Small-Cap ETF 0.01 67.26
IDEV iShares Core MSCI International Developed Markets ETF 0.01 79.68
XEU.TO iShares MSCI Europe IMI Index ETF 0.01 35.92
XEF.TO iShares Core MSCI EAFE IMI Index ETF 0 44.96
WSML.L iShares MSCI World Small Cap UCITS ETF 0.02 8.755
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.02 7.469
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.02 6.46
Unlock